Moody's places Cabot's (CBT) Baa1 rating under review for a possible downgrade
- AbbVie (ABBV) to Acquire Pharmacyclics (PCYC) for $21 Billion
- Market Wrap: Job Additions Light in Feb.; McDonald's Plans Better Product Sourcing; Lumber Liquidators Chopped Again
- Etsy (ETSY) Files $100 Million IPO
- After-Hours Stock Movers 03/04: (RNDY) (PEIX) (PCYC) Higher; (SMTC) (VNDA) (ECA) Lower (more...)
- ADP Employment Change 212K vs 219K Expected
Moody's places Cabot's (NYSE: CBT) Baa1 rating under review for a possible downgrade
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cabot Norit Activated Carbon Used to Purify Tulsa’s Award Winning Water
- Best Buy (BBY) Target Lifted to $45 at SunTrust Robinson Humphrey Post Q4
- Nomura Securities Downgrades Abercrombie & Fitch (ANF) to Neutral
Create E-mail Alert Related CategoriesCredit Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!